Serve as the primary owner of US market understanding for the asset, including patient journey, diagnosis and referral dynamics, treatment paradigms, competitive landscape, and unmet need.
Translate clinical data and emerging evidence into US-relevant value narratives for HCPs, patients, and payers.
Lead US-focused market research, insight generation, and forecasting efforts to inform strategic decision-making.
Design the US go-to-market strategy from first principles, including positioning, segmentation, targeting hypotheses, and launch sequencing.
Partner closely with Market Access to inform early pricing, access, and reimbursement scenarios appropriate for the US healthcare system.
Define launch readiness requirements across marketing, medical, access, sales, patient services, and operations, ensuring alignment and integration, and driving execution to ensure launch readiness.
Lead development of the US Brand Plan and US Launch Plan in alignment with global strategy while advocating for US-specific needs and trade-offs.
Act as the US commercial representative into the Global Brand Team, contributing meaningfully to global positioning, product profile development, and launch strategy.
Lead US pre-launch market shaping activities in partnership with Medical, Patient Advocacy, and Policy, ensuring appropriate readiness while remaining compliant.
Build relationships with key external stakeholders (thought leaders, advocacy organizations) in coordination with Medical Affairs.
Operate initially as a hands-on leader , while designing the future US brand organization and capabilities needed for launch.